12-47738710-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001098531.4(RAPGEF3):āc.2506C>Gā(p.Leu836Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000124 in 1,609,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 6.9e-7 ( 0 hom. )
Consequence
RAPGEF3
NM_001098531.4 missense
NM_001098531.4 missense
Scores
4
11
4
Clinical Significance
Conservation
PhyloP100: 4.53
Genes affected
RAPGEF3 (HGNC:16629): (Rap guanine nucleotide exchange factor 3) Enables guanyl-nucleotide exchange factor activity and protein domain specific binding activity. Involved in several processes, including positive regulation of protein modification process; regulation of actin cytoskeleton organization; and regulation of syncytium formation by plasma membrane fusion. Located in filopodium; lamellipodium; and microvillus. Colocalizes with cortical actin cytoskeleton and plasma membrane. Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.815
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAPGEF3 | NM_001098531.4 | c.2506C>G | p.Leu836Val | missense_variant | 25/28 | ENST00000449771.7 | NP_001092001.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAPGEF3 | ENST00000449771.7 | c.2506C>G | p.Leu836Val | missense_variant | 25/28 | 2 | NM_001098531.4 | ENSP00000395708.2 | ||
RAPGEF3 | ENST00000389212.7 | c.2506C>G | p.Leu836Val | missense_variant | 26/29 | 2 | ENSP00000373864.3 | |||
RAPGEF3 | ENST00000549151.5 | c.2380C>G | p.Leu794Val | missense_variant | 25/28 | 5 | ENSP00000448619.1 | |||
RAPGEF3 | ENST00000548919.5 | c.2179C>G | p.Leu727Val | missense_variant | 24/27 | 2 | ENSP00000448480.1 | |||
RAPGEF3 | ENST00000547856.5 | n.*1814C>G | non_coding_transcript_exon_variant | 21/24 | 2 | ENSP00000449905.1 | ||||
RAPGEF3 | ENST00000547856.5 | n.*1814C>G | 3_prime_UTR_variant | 21/24 | 2 | ENSP00000449905.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1457146Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 725288
GnomAD4 exome
AF:
AC:
1
AN:
1457146
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
725288
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74346
GnomAD4 genome
AF:
AC:
1
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.2506C>G (p.L836V) alteration is located in exon 25 (coding exon 25) of the RAPGEF3 gene. This alteration results from a C to G substitution at nucleotide position 2506, causing the leucine (L) at amino acid position 836 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;.;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;.;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N;N;N;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
D;.;.;D;.
Vest4
MutPred
Gain of catalytic residue at T831 (P = 0.0016);.;.;Gain of catalytic residue at T831 (P = 0.0016);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at